This hub is published for Research Use Only (RUO) and addresses preclinical Alzheimer's disease biology. It is entirely distinct from the stroke NMDA excitotoxicity/BBB content (ID 77529), the anxiety/depression HPA axis/BDNF content (ID 77519), and all prior posts in this series. The amyloid processing, tau pathology, TREM2 microglial, and cholinergic neurodegeneration biology discussed here is…
William
This hub is published for Research Use Only (RUO) and addresses preclinical sexual function neurobiology. It is entirely distinct from the Melanotan-II comparison post in this series (which focused on MC1R tanning and peripheral MC receptor selectivity), the anxiety/depression neuromodulation content (ID 77519), and all prior posts. The central MC4R/dopaminergic/NO-independent erectile biology discussed here is…
This comparison post is published for Research Use Only (RUO) and addresses preclinical GH secretagogue pharmacology. It is entirely distinct from the CJC-1295 vs Sermorelin GHRH-receptor pharmacology (ID 77521), the Ipamorelin vs GHRP-2 GHS-R1a selectivity comparison (ID 77510), and all prior posts in this series. Hexarelin's unique CD36 receptor biology and cardioprotective mechanisms discussed here…
Important regulatory notice. No peptide sold as a research-use-only reference compound is licensed by the MHRA as an osteoporosis medicine in the United Kingdom. This page is a literature-context overview of compound families discussed in published bone-biology research. It is not personal-use guidance. Peptides Lab UK supplies research-use-only laboratory reference compounds. Products are not for…
This hub is published for Research Use Only (RUO) and addresses preclinical rheumatoid arthritis biology. It is entirely distinct from the stroke neuroinflammation content (ID 77529), the IBD mucosal cytokine content (ID 77523), the heart failure NLRP3 content (ID 77527), and all prior posts in this series. The synovial pannus, RA synoviocyte (FLS), and joint…
This hub is published for Research Use Only (RUO) and addresses preclinical stroke and cerebrovascular biology. It is entirely distinct from the anxiety/depression neuroplasticity content (ID 77519), the CKD podocyte/renal fibrosis content published in the preceding post, and all prior posts in this series. The ischaemic excitotoxicity, BBB disruption, and post-stroke neuroinflammation biology discussed here…
This hub is published for Research Use Only (RUO) and addresses preclinical chronic kidney disease biology. It is entirely distinct from the heart failure RAAS/cardiac fibrosis content (ID 77527), the liver fibrosis hepatic stellate cell content (ID 77515), the IBD mucosal barrier content (ID 77523), and all prior posts in this series. The renal tubular,…
This hub is published for Research Use Only (RUO) and addresses preclinical heart failure biology. It is entirely distinct from the PCOS neuroendocrine content published in the preceding post, the IBD mucosal barrier content (ID 77523), the lung cancer tumour microenvironment content (ID 77522), and all prior posts in this series. The cardiac remodelling, RAAS,…
Important regulatory notice. No peptide sold as a research-use-only reference compound is licensed by the MHRA as a treatment for polycystic ovary syndrome (PCOS) in the United Kingdom. This page is a literature-context overview of compound families discussed in published PCOS research. It is not personal-use guidance. Peptides Lab UK supplies research-use-only laboratory reference compounds.…
This hub is published for Research Use Only (RUO) and addresses preclinical endometriosis biology. It is entirely distinct from the ovarian cancer BRCA/HRD/PARPi content published in the preceding post, the PCOS LH/FSH/GnRH content planned in upcoming posts, and all prior IBD, liver, lung, and neurological content in this series. No content constitutes medical advice, clinical…
This hub is published for Research Use Only (RUO) and addresses preclinical ovarian cancer biology. It is entirely distinct from the prostate cancer androgen receptor content (ID 77520), the lung cancer KRAS/EGFR/ALK hub (ID 77522), and all prior cancer hubs in this series. The BRCA/HRD/PARP biology discussed here is not shared with any prior post.…
This hub is published for Research Use Only (RUO) and addresses preclinical inflammatory bowel disease biology. It is entirely distinct from the BPC-157 general gut motility content in prior posts and from the anxiety/depression neuroimmune content (ID 77519), the liver fibrosis hepatic stellate cell content (ID 77515), and the lung cancer TME content published in…
